Cutaneous yeast microflora in patients with atopic dermatitis

• Authors: Aukse Zinkeviciene , Nemira Vaiciulioniene , Irena Baranauskiene , Violeta Kvedariene , Regina Emuzyte , Donaldas Citavicius
• Languages of publication: EN

Abstracts

EN

The skin of persons with atopic dermatitis (AD) is very susceptible to cutaneous infection, and some yeast species may also aggravate AD. The total yeast population of an AD patient’s skin and its relation with individual age and body part remains poorly characterized. The aim of this study was to clarify the differences in cutaneous yeast flora by age and body parts of AD patients.By swabbing affected body parts (hands, legs, face, neck or trunk), 241 samples were collected from patients with AD (132 children and 109 adults), and as controls, 40 samples were taken from healthy individuals (20 children, 20 adults).In all, 89 (36.9%) of samples were positive; the yeast isolated belonged to three genera: Candida (27.4%), Malassezia (6.6%), and Rhodotorula (2.9%). Cutaneous colonization with yeasts was two-fold higher in the adults than in children (P<0.0001). The distribution of the yeast species was dependent on the body part sampled: Malassezia predominated in the face, neck, and trunk regions (P=0.0047); Candida more frequently colonized hands and legs (P=0.0029).Our study showed that cutaneous yeast flora and distribution of yeast species depends significantly on the age of the AD patient and the body part affected by atopic dermatitis.

Keywords

EN

Atopic dermatitis; Yeast; Malassezia; Candida

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2011
• Volume: 6
• Issue: 6
• Pages: 713-719

Dates

published

1 - 12 - 2011

online

8 - 10 - 2011

Contributors

author

Aukse Zinkeviciene

author

Nemira Vaiciulioniene

author

Irena Baranauskiene

author

Violeta Kvedariene

author

Regina Emuzyte

• Faculty of Medicine, Clinic of children diseases, Vilnius University, Antakalnio 57, LT-10207, Vilnius, Lithuania

author

Donaldas Citavicius

• Department of Microbiology and Biotechnology, Faculty of Natural Sciences, Vilnius University, M.K. Ciurlionio 21/27, LT-03101, Vilnius, Lithuania

References

• [1] Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al., Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report, Allergy, 2006, 61, 969–987 [Crossref]
• [2] Williams H., Robertson C., Stewart A., Ait-Khaled N., Anabwani G., Anderson R., et al., Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood, J Allergy Clin Immunol, 1999, 103, 125–138 http://dx.doi.org/10.1016/S0091-6749(99)70536-1[Crossref]
• [3] Batiles Garrido J., Torres-Borego J., Bonilio Perales A., Rubi Ruiz T., González Jiménez Y., Momblán De Cabo J., et al., Prevalence and factors linked to atopic eczema in 10- and 11-year-old schoolchildren. Isaac 2 in Almeria, Spain, Allergol Immunopathol, 2010, 38, 174–180 http://dx.doi.org/10.1016/j.aller.2009.10.008[Crossref]
• [4] Simpson C.R., Newton J., Hippisley-Cox J., Sheikh A., Trends in the epidemiology and prescribing of medication for eczema in England, J R Soc Med, 2009, 102, 108–117 http://dx.doi.org/10.1258/jrsm.2009.080211[Crossref]
• [5] Hwang C.Y., Chen Y.J., Lin M.W., Chen T.J., Chu S.Y., Chen C.C., et al., Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007, Acta Derm Venereol, 2010, 90, 589–594 http://dx.doi.org/10.2340/00015555-0963[Crossref]
• [6] Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., et al., Worldwide time trends in the prevalence of symptoms of astma, allergic rhinoconjunctivitis, and egzema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys, Lancet, 2006, 368, 733–743 http://dx.doi.org/10.1016/S0140-6736(06)69283-0[Crossref]
• [7] Strachan D.P., Hay fever, hygiene and household size, Br Med, 1989, 299, 1259–1260 http://dx.doi.org/10.1136/bmj.299.6710.1259[Crossref]
• [8] Lubbe J., Secondary infections in patients with atopic dermatitis, Am J Clin Dermatol, 2003, 4, 641–654 http://dx.doi.org/10.2165/00128071-200304090-00006[Crossref]
• [9] Ashbee H.R., Evans E.G.V., Immunology of diseases associated with Malassezia species, Clin Microbiol Rev, 2002, 15, 21–57 http://dx.doi.org/10.1128/CMR.15.1.21-57.2002[Crossref]
• [10] Nakabayshi A., Sei Y., Guillot J., Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects, Med Mycol, 2000, 38, 337–341 [Crossref]
• [11] Savolainen J., Lintu P., Kosonen J., Kortekangas-Savolainen O., Viander M., Pène J., et al., Pityrosporum and Candida specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients, Clin Exp Allergy, 2001, 31, 125–134 [Crossref]
• [12] Rincón S., Celis A., Sopó L., Motta A., Cepero de Garcia M.C., Malassezia yeast species isolated from patients with dermatologic lesions, Biomedica, 2005, 25, 189–195 [Crossref]
• [13] Yim S.M., Kim J.Y., Ko J.H., Lee Y.W., Choe Y.B., Ahn K.J., Molecular analysis of Malassezia micro-flora on the skin of the patients with atopic dermatitis, Ann Dermatol, 2010, 22, 41–47 http://dx.doi.org/10.5021/ad.2010.22.1.41[Crossref]
• [14] Scheynius A., Johansson C., Buentke E., Zargari A., Linder M.T., Atopic eczema/dermatitis syndrome and Malassezia, Int Arch Allergy Immunol, 2002, 127, 161–169 http://dx.doi.org/10.1159/000053860[Crossref]
• [15] Selander C., Zargari A., Möllby R., Rasool O., Scheynius A., Higher pH level, corresponding to that on the skin of patients with atopic eczema, stimulates the release of Malassezia sympodialis allergens, Allergy, 2006, 61, 1002–1008 http://dx.doi.org/10.1111/j.1398-9995.2006.01108.x[Crossref]
• [16] Nikkels A.F., Pierard G.E., Framing the future of antifungals in atopic dermatitis, Dermatology, 2003, 206, 398–400 http://dx.doi.org/10.1159/000069968[Crossref]
• [17] Baldo B.A., Allergenic crossreactivity of fungi with emphasis on yeasts: strategies for further study, Clin Exp Allergy, 1995, 25, 488–492 http://dx.doi.org/10.1111/j.1365-2222.1995.tb01085.x[Crossref]
• [18] Huang X., Johansson S.G.O., Zargari A., Nordvall S.L., Allergen cross reactivity between Pityrosporum orbiculare and Candida albicans, Allergy, 1995, 50, 648–656 http://dx.doi.org/10.1111/j.1398-9995.1995.tb02581.x[Crossref]
• [19] Lintu P., Savolainen J., Kalimo K., Kortekangas-Savolainen O., Nermes M., Terho E.O., Crossreacting IgE and IgG antibodies to Pityrosporum ovale mannan and other yeasts in atopic dermatitis, Allergy, 1999, 54, 1067–1073 http://dx.doi.org/10.1034/j.1398-9995.1999.00091.x[Crossref]
• [20] Yasueda H., Hashida-Okado T., Saito A., Uchida K., Kuroda M., Onishi Y., et al., Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur, Biochemical and Biophysical research communications, 1998, 248, 240–244 http://dx.doi.org/10.1006/bbrc.1998.8944[Crossref]
• [21] Wagner S., Breiteneder H., Simon-Nobbe B., Susani M., Krebitz M., Niggemann B., et al., Hev b 9, an enolase and a new cross-reactive allergen from Hevea latex and molds. Purification, characterization, cloning and expression, Eur J Biochem, 2000, 267, 7006–7014 http://dx.doi.org/10.1046/j.1432-1327.2000.01801.x[Crossref]
• [22] O’Neil C.E., Horner W.E., Reed M.A., Lopez M., Lehrer S.B., Evaluation of Basidiomycete and Deuteromycete (Funfi Imperfecti) extracts for shared allergenic determinants, Clin Exp Allergy,1990, 20, 533–538 http://dx.doi.org/10.1111/j.1365-2222.1990.tb03146.x[Crossref]
• [23] Andersson A., Rasool O., Schmidt M., Kodzius R., Fluckiger S., Zargari A., et al., Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase, Eur J Biochem, 2004, 271, 1885–1894 http://dx.doi.org/10.1111/j.1432-1033.2004.04098.x[Crossref]
• [24] Aspres N., Anderson C., Malassezia yeasts in the pathogenesis of atopic dermatitis, Australas J Dermatol, 2004, 45, 199–207 http://dx.doi.org/10.1111/j.1440-0960.2004.00097.x[Crossref]
• [25] Sugita T., Tajima M., Tsubuku H., Tsuboi R., Nishikawa A., Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using realtime PCR, Microbiol Immunol, 2006, 50, 549–552 [Crossref]
• [26] Kato H., Sugita T., Ishibashi Y., Nishikawa A., Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzymelinked immunosorbent assay, Microbiol Immunol, 2006, 50, 851–856 [Crossref]
• [27] Takahata Y., Sugita T., Kato H., Nishikawa A., Hiruma M., Muto M., Cutaneous Malassezia flora in atopic dermatitis differs between adults and children, Br J Dermatol, 2007, 157, 1178–1182 http://dx.doi.org/10.1111/j.1365-2133.2007.08193.x[Crossref]
• [28] Devos S.A., van der Valk P.G., The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis, Allergy, 2000, 55, 1056–1058 http://dx.doi.org/10.1034/j.1398-9995.2000.00782.x[Crossref]
• [29] Hanifin J.M., Rajka G., Diagnostic features of atopic dermatitis, Acta Derm Venereol, 1980, 92, 44–47
• [30] Kurtzman C.P., Fell J.W., The yeasts, a taxonomic study, 4th edn., Amsterdam: Elsevier Science Publishing, 1998
• [31] Guillot J., Guého E., Lesourd G., Midgley G., Cheevrier G., Dupont B., Identification of Malassezia species. A practical approach, J Mycol Med, 1996, 6, 103–110
• [32] Guého E., Midgley G., Guillot J., The genus Malassezia with description of four new species, Antonie Leeuwenhoek, 1996, 69, 337–355 http://dx.doi.org/10.1007/BF00399623[Crossref]
• [33] Mayser P., Haze P., Papavassilis C., Pickel M., Gruender K., Gueho E., Differentiation of Malassezia species: selectivity of cremophor EL, castor oil and ricinoleic acid for M.furfur, Br J Dermatol, 1997, 137, 208–213 http://dx.doi.org/10.1046/j.1365-2133.1997.18071890.x[Crossref]
• [34] Mayser P., Töws A., Krämer H.J., Weiß R., Further characterization of pigment-producing Malassezia strains, Mycoses, 2004, 47, 34–39 http://dx.doi.org/10.1046/j.1439-0507.2003.00957.x[Crossref]
• [35] Mayser P., Wille G., Imkampe A., Thoma W., Monsees T., Arnold N., Synthesis of fluorochromes and pigments in Malassezia furfur by use of tryptophan as the single nitrogen source, Mycoses, 1998, 41, 265–271 http://dx.doi.org/10.1111/j.1439-0507.1998.tb00336.x[Crossref]
• [36] Saghazadeh M., Farshi S., Hashemi J., Mansouri P., Khosravi A.R., Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, and normal subjects, J Mycol Med, (in press), DOI:10.1016/j.mycmed. 2010.08.003 [Crossref]
• [37] Faergemann J., Atopic Dermatitis and Fungi, Clin Microbiol Rev, 2002, 15, 545–563 http://dx.doi.org/10.1128/CMR.15.4.545-563.2002[Crossref]
• [38] Farhadi A., Banan A, Fields J., Keshavarzian A., Intestinal barrier: an interface between health and disease, J Gastroenterol Hepatol, 2003, 18, 479–497 http://dx.doi.org/10.1046/j.1440-1746.2003.03032.x[Crossref]
• [39] Yamaguchi N., Sugita R., Miki A., Takemura N., Kawataba J., Watanabe J., et al., Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice, 2006, 55, 954–960
• [40] Akaza N., Akamatsu H., Sasaki Y., Takeoka S., Kishi M., Mizutani H., et al., Cutaneous Malassezia microbiota of healthy subjects differ by sex, body part and season, Journal of Dermatology, 2010, 37, 786–792 http://dx.doi.org/10.1111/j.1346-8138.2010.00913.x[Crossref]
• [41] Bunikowski R., Mielke M.E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., et al., Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis, J Allergy Clin Immunol, 2000, 105, 814–819 http://dx.doi.org/10.1067/mai.2000.105528[Crossref]
• [42] Bunikowski R., Mielke M., Skarabis H., Herz U., Bergmann R.L., Wahn U., et al., Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis, J Allergy Clin Immunol, 1999, 103, 119–124 http://dx.doi.org/10.1016/S0091-6749(99)70535-X[Crossref]
• [43] Cunningham A.C., Ingham E., Gowland G., Humoral responces to Malassezia furfur serovars A, B and C in normal individuals of various ages, Br J Dermatol, 1992, 127, 476–481 http://dx.doi.org/10.1111/j.1365-2133.1992.tb14843.x[Crossref]
• [44] Gupta A.K., Batra R., Bluhm R., Boekhout T., Dawson T., Skin disease associated with Malassezia species, J Am Acad Dermatol, 2004, 51, 785–798 http://dx.doi.org/10.1016/j.jaad.2003.12.034[Crossref]
• [45] Golubev W., Mycocins (Killer toxins), In: The yeasts, a taxonomic study, Kurtzman C.P., Fell J.W., 4th edn. Amsterdam: Elsevier Science Publishing, 1998
• [46] Kitagaki H., Fujisawa S., Watanabe K., Hayakawa K., Shiohara T., Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice, J Invest Dermatol, 1995, 105, 749–755 http://dx.doi.org/10.1111/1523-1747.ep12325538[Crossref]
• [47] Hemmann S., Blaser K., Crameri R., Allergens of Aspergillus fumigatus and Candida boidinii Share IgE-binding Epitopes, Am J Respir Crit Care Med, 1997, 156, 1956–1962
• [48] Sharma V., Singh B.P., Gaur S.N., Arora N., Molecular and immunological characterization of cytochrome c: a potential cross-reactive allergen in fungi and grasses, Allergy, 2008, 63, 189–197 http://dx.doi.org/10.1111/j.1398-9995.2007.01528.x[Crossref]
• [49] Simon-Nobbe B., Probst G., Kajava A.V., Oberkofler H., Susani M., Crameri R., et al., IgE-binding epitopes of enolases, a class of highly conserved fungal allergens, J Allergy Clin Immunol, 2000, 106, 887–895 http://dx.doi.org/10.1067/mai.2000.110799[Crossref]
• [50] Shankar J., Gupta P.D., Sridhara S., Singh B.P., Gaur S.N., Arora N., Immunobiochemical analysis of cross-reactive glutathione-S-transferase allergen from different fungal sources, Immunol Invest, 2005, 34, 37–51
• [51] Pöll V., Denk U., Shen H.D., Panzani R.C., Dissertori O., Lackner P., et al., The vacuolar serine protease, a cross-reactive allergen from Cladosporium herbarum, Mol Immunol, 2009, 46, 1360–1373 http://dx.doi.org/10.1016/j.molimm.2008.11.017[Crossref]
• [52] Simon-Nobbe B., Denk U., Pöll V., Rid R., Breitenbach M., The spectrum of fungal allergy, Int Arch Allergy Immunol, 2008, 145, 58–86 http://dx.doi.org/10.1159/000107578[Crossref]
• [53] Kanbe T., Utsunomiya K., Ishiguro A., A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species, Clin Exp Allergy, 1997, 27, 1449–1457 http://dx.doi.org/10.1111/j.1365-2222.1997.tb02990.x[Crossref]
• [54] Savolainen J., Kortekangas-Savolainen O., Nermes M., Viander M., Koivikko A., Kalimo K., et al., IgE, IgA and IgG responses to common yeasts in atopic patients, Allergy, 1998, 53, 506–512 http://dx.doi.org/10.1111/j.1398-9995.1998.tb04088.x[Crossref]

Identifiers

DOI

10.2478/s11536-011-0075-4